TP53 and breast carcinoma: Cell proliferation experiments revealed that GSK2830371 efficiently suppressed proliferation of tumor cells carrying PPM1D amplification while retaining wild-type TP53, including hematological cancer, neuroblastoma, and breast cancer cell lines [57, 80, 89, 96, 97].